Sentry Investment Management LLC reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 4.5% during the first quarter, Holdings Channel reports. The fund owned 24,920 shares of the financial services provider’s stock after selling 1,172 shares during the period. Sentry Investment Management LLC’s holdings in CME Group were worth $2,960,000 as of its most recent filing with the SEC.
Several other institutional investors have also made changes to their positions in the stock. Pitcairn Co. raised its stake in CME Group by 0.4% in the first quarter. Pitcairn Co. now owns 3,247 shares of the financial services provider’s stock valued at $386,000 after buying an additional 14 shares in the last quarter. Buffington Mohr McNeal raised its stake in CME Group by 0.3% in the first quarter. Buffington Mohr McNeal now owns 4,795 shares of the financial services provider’s stock valued at $570,000 after buying an additional 15 shares in the last quarter. Summit Asset Management LLC raised its stake in CME Group by 0.5% in the first quarter. Summit Asset Management LLC now owns 3,016 shares of the financial services provider’s stock valued at $358,000 after buying an additional 16 shares in the last quarter. Assetmark Inc. raised its stake in CME Group by 1.4% in the first quarter. Assetmark Inc. now owns 1,423 shares of the financial services provider’s stock valued at $169,000 after buying an additional 19 shares in the last quarter. Finally, Buckingham Asset Management LLC raised its stake in CME Group by 0.9% in the first quarter. Buckingham Asset Management LLC now owns 2,671 shares of the financial services provider’s stock valued at $317,000 after buying an additional 25 shares in the last quarter. 83.55% of the stock is currently owned by institutional investors.
CME Group Inc. (NASDAQ CME) opened at 124.12 on Monday. CME Group Inc. has a 52 week low of $92.29 and a 52 week high of $127.74. The company’s 50-day moving average price is $119.55 and its 200-day moving average price is $119.67. The company has a market capitalization of $42.17 billion, a P/E ratio of 26.87 and a beta of 0.75.
CME Group (NASDAQ:CME) last posted its earnings results on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.02. The business had revenue of $929 million during the quarter, compared to the consensus estimate of $932.06 million. CME Group had a return on equity of 7.43% and a net margin of 43.62%. CME Group’s revenue was down .5% on a year-over-year basis. During the same quarter last year, the company earned $1.15 EPS. On average, equities analysts forecast that CME Group Inc. will post $4.87 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, June 26th. Investors of record on Friday, June 9th will be given a dividend of $0.66 per share. The ex-dividend date is Wednesday, June 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.13%. CME Group’s dividend payout ratio (DPR) is presently 57.14%.
Several research firms recently issued reports on CME. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a research report on Friday. Royal Bank Of Canada upped their price target on CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a research report on Tuesday, June 20th. Deutsche Bank AG reissued a “buy” rating and set a $133.00 price target (down from $134.00) on shares of CME Group in a research report on Monday, May 15th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research report on Monday, March 20th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Saturday, March 11th. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $117.50.
In related news, insider Kathleen M. Cronin sold 8,125 shares of the firm’s stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $127.35, for a total transaction of $1,034,718.75. Following the completion of the transaction, the insider now owns 38,174 shares in the company, valued at approximately $4,861,458.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, April 10th. The stock was sold at an average price of $117.85, for a total value of $294,625.00. Following the transaction, the chief financial officer now owns 40,995 shares of the company’s stock, valued at approximately $4,831,260.75. The disclosure for this sale can be found here. Insiders have sold a total of 48,754 shares of company stock valued at $5,939,099 in the last 90 days. 0.61% of the stock is owned by corporate insiders.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/sentry-investment-management-llc-lowers-stake-in-cme-group-inc-cme/1940058.html
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.